{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:09:16Z","timestamp":1759615756368,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41433-021-01468-3","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T11:04:53Z","timestamp":1614337493000},"page":"135-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Do topical ocular antihypertensives affect Dacryocystorhinostomy outcomes: The Coventry experience"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8330-7232","authenticated-orcid":false,"given":"Priyanka","family":"Mandal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"key":"1468_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00002341-199212000-00001","volume":"8","author":"GB Bartley","year":"1992","unstructured":"Bartley GB. Acquired lacrimal drainage obstruction: an etiologic classification system, case reports, and a review of the literature. Part 1. Ophthalmic Plast Reconstr Surg. 1992;8:237\u20132.","journal-title":"Ophthalmic Plast Reconstr Surg."},{"key":"1468_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/01676830903207828","volume":"29","author":"MB Kashkouli","year":"2010","unstructured":"Kashkouli MB, Sadeghipour A, Kaghazkanani R, Bayat A, Pakdel F, Aghai GH. Pathogenesis of primary acquired nasolacrimal duct obstruction. Orbit. 2010;29:11\u20135.","journal-title":"Orbit."},{"key":"1468_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2147\/OPTH.S44708","volume":"8","author":"K Inoue","year":"2014","unstructured":"Inoue K. Managing adverse effects of glaucoma medications. Clin Ophthalmol. 2014;8:903\u201313.","journal-title":"Clin Ophthalmol."},{"key":"1468_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2165\/11588830-000000000-00000","volume":"28","author":"JJ Servat","year":"2011","unstructured":"Servat JJ, Bernardino CR. Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue. Drugs Aging. 2011;28:267\u201382.","journal-title":"Drugs Aging."},{"key":"1468_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2165\/00128071-200001060-00003","volume":"1","author":"PO Fritsch","year":"2000","unstructured":"Fritsch PO, Sidoroff A. Drug-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis. Am J Clin Dermatol. 2000;1:349\u201360.","journal-title":"Am J Clin Dermatol."},{"key":"1468_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","volume":"54","author":"M Lerch","year":"2018","unstructured":"Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54:147\u201376.","journal-title":"Clin Rev Allergy Immunol."},{"key":"1468_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/jop.2007.0058","volume":"24","author":"V Munshi","year":"2008","unstructured":"Munshi V, Ahluwalia H. Erythema multiforme after use of topical dorzolamide. J Ocul Pharm Ther. 2008;24:91\u20133.","journal-title":"J Ocul Pharm Ther."},{"key":"1468_CR8","first-page":"47","volume":"25","author":"VM Asensio-S\u00e1nchez","year":"2008","unstructured":"Asensio-S\u00e1nchez VM. Toxic epidermal necrolysis following dorzolamide eyedrops. Med Interna. 2008;25:47\u20138.","journal-title":"Med Interna."},{"key":"1468_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5021\/ad.2008.20.4.260","volume":"20","author":"JS Chun","year":"2008","unstructured":"Chun JS, Yun SJ, Lee JB, Kim SJ, Won YH, Lee SC. Toxic epidermal necrolysis induced by the topical carbonic anhydrase inhibitors brinzolamide and dorzolamide. Ann Dermatol. 2008;20:260\u20132.","journal-title":"Ann Dermatol."},{"key":"1468_CR10","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaip.2019.09.032","volume":"8","author":"MS Yang","year":"2020","unstructured":"Yang MS, Lee JY, Kim J, Kim GW, Kim BK, Kim JY, et al. Searching for the culprit drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis from a nationwide claim database in Korea. J Allergy Clin Immunol Pract. 2020;8:690\u20135.e2.","journal-title":"J Allergy Clin Immunol Pract."},{"key":"1468_CR11","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","volume":"112","author":"DC Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112:1446\u201354.","journal-title":"Arch Ophthalmol."},{"key":"1468_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ophtha.2011.09.043","volume":"119","author":"J Landers","year":"2012","unstructured":"Landers J, Martin K, Sarkies N, Bourne R, Watson P. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology. 2012;119:694\u2013702.","journal-title":"Ophthalmology."},{"key":"1468_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ajo.2007.07.033","volume":"145","author":"N Seider","year":"2008","unstructured":"Seider N, Miller B, Beiran I. Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction. Am J Ophthalmol. 2008;145:120\u20133.","journal-title":"Am J Ophthalmol."},{"key":"1468_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/IOP.0b013e3181706829","volume":"24","author":"MB Kashkouli","year":"2008","unstructured":"Kashkouli MB, Rezaee R, Nilforoushan N, Salimi S, Foroutan A, Naseripour M. Topical antiglaucoma medications and lacrimal drainage system obstruction. Ophthalmic Plast Reconstr Surg. 2008;24:172\u20135.","journal-title":"Ophthalmic Plast Reconstr Surg."},{"key":"1468_CR15","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121:2081\u201390.","journal-title":"Ophthalmology"},{"key":"1468_CR16","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/sj.eye.6700576","volume":"17","author":"J Dart","year":"2003","unstructured":"Dart J. Corneal toxicity: the epithelium and stroma in iatrogenic and factitious disease. Eye. 2003;17:886\u201392.","journal-title":"Eye."},{"key":"1468_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/jop.2018.0124","volume":"35","author":"S Tekin","year":"2019","unstructured":"Tekin S, Seven E, Batur M. Evaluation of antiglaucomatous drops on conjunctival thickness in patients with primary open-angle glaucoma. J Ocul Pharm Ther. 2019;35:216\u201322.","journal-title":"J Ocul Pharm Ther."},{"key":"1468_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ophtha.2006.09.032","volume":"114","author":"V Hegde","year":"2007","unstructured":"Hegde V, Robinson R, Dean F, Mulvihill HA, Ahluwalia H. Drug-induced ectropion: what is best practice. Ophthalmology. 2007;114:362\u20136.","journal-title":"Ophthalmology."},{"key":"1468_CR19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labb\u00e9 A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29:312\u201334.","journal-title":"Prog Retin Eye Res."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01468-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01468-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01468-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T11:04:23Z","timestamp":1641294263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01468-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01468-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"type":"print","value":"0950-222X"},{"type":"electronic","value":"1476-5454"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"11 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}